Skip to content
[International Medical Forum · Event]

Redefining Healthcare

A New Generation of Clinical Therapy Driven by AI, Robotics, and Medical Imaging

AMED Ventures

Mega Room, 8F, W Taipei

About the forum

An afternoon of clinical insight and cross-disciplinary dialogue on the forces shaping the next generation of healthcare.

AMED Ventures will host an international medical forum titled “Redefining Healthcare: A New Generation of Clinical Therapy Driven by AI, Robotics, and Medical Imaging” on Thursday, September 10, 2026, at 2:00 p.m. in the Mega Room on the 8th floor of W Taipei. We warmly invite you to join us.

The forum will bring together speakers from the fields of medical devices, cardiovascular medicine, urology, and healthcare innovation to discuss how AI, robotics, medical imaging, and unmet clinical needs are driving the next generation of medical innovation.

The keynote speaker, Amr Salahieh, is an internationally recognized serial entrepreneur in medical devices. As Founder and CEO of Shifamed, he brings more than 30 years of industry experience and has founded and led multiple medical device startups, with a longstanding focus on cardiovascular and minimally invasive innovation.

Event information

Date
Time
  • 2:00–4:40 p.m.
  • Check-in from 1:30 p.m.
VenueMega Room, 8F, W TaipeiNo. 10, Sec. 5, Zhongxiao E. Rd., Xinyi Dist., Taipei City
OrganizerAMED Ventures
ContactHank Huang · Finance & Investment Management Managerhankh@amedventures.com02-25796866

Forum schedule

TimeProgramSpeaker
13:30–14:00Mega Room, 8F, W TaipeiRegistration
14:00–14:10Opening remarks

Michael WangChairman & Managing Partner, AMED Ventures

14:10–14:50Keynote 01How Shifamed Is Leading in Interventional Cardiology Using AI and Robotics

Amr SalahiehFounder & CEO, Shifamed LLC

14:50–15:20Keynote 02Redefining Urology: AI, Medical Imaging and Robotics Transforming Patient Care

Dr. Jian-Yi LeeDirector, Department of Urology, Taichung Veterans General Hospital

15:20–15:40Intermission
15:40–16:10Keynote 03Back to the Fundamentals, Beyond Technology: Driving Healthcare Innovation Through Patient and Healthcare System Needs

Dr. Kuan ChenVenture Partner & Medical Advisor, AMED Ventures

16:10–16:40Networking and discussion

Featured speakers

Leaders across medtech, clinical practice, and venture investing share perspectives from innovation to patient care.

Michael Wang

Michael Wang

Chairman & Managing PartnerAMED Ventures

Michael Wang leads AMED Ventures' strategy and investments across U.S. medtech and healthcare innovation with global growth potential. With more than three decades of experience spanning entrepreneurship, corporate leadership, investment, and strategic partnerships, he continues to support the advancement of Taiwan's electronics and medical device industries.

William Tai

William Tai

Managing PartnerAMED Ventures

William Tai brings more than 25 years of corporate investment and venture capital experience across U.S. and international markets. He has deep expertise in the medical device value chain, cross-border business development, strategic partnerships, collaborative product development, and contract manufacturing.

Amr Salahieh

Amr Salahieh

Founder & CEOShifamed

An internationally recognized serial entrepreneur with more than 30 years of medical device experience, Amr Salahieh has founded and led multiple startups focused on cardiovascular and minimally invasive innovation. He is named on more than 400 issued and pending patents worldwide.

Dr. Jian-Yi Lee

Dr. Jian-Yi Lee

Director, Department of UrologyTaichung Veterans General Hospital

Dr. Jian-Yi Lee is Director of the Department of Urology at Taichung Veterans General Hospital. His session explores how AI, medical imaging, and robotics are transforming the diagnosis and treatment of urologic conditions.

Dr. Kuan Chen

Dr. Kuan Chen

Venture Partner & Medical AdvisorAMED Ventures

An orthopedic surgeon with a UC Berkeley bioengineering background and medical device design expertise, Dr. Kuan Chen brings clinical and translational experience to early-stage investing. His work focuses on whether innovation responds to real patient, care-team, and healthcare-system needs.

AMED Ventures page